Azitra (AZTR) Current Leases (2022 - 2026)

Azitra (AZTR) posted Current Leases of $5850.0 for Q1 2026, down 97.71% on a QoQ basis from $255776.0 in Q4 2025, and down 97.54% year-over-year from $237647.0 in Q1 2025.

Azitra (AZTR) Current Leases (2022 - 2026) Analysis & Trends

Azitra's Current Leases history runs 5 years deep, the most recent figure standing at $5850.0 for Q1 2026.

  • Quarterly Current Leases fell 97.54% year-over-year to $5850.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5850.0 (down 97.54% YoY) and the FY2025 annual result came in at $255776.0, up 1492.03% from the prior year.
  • Current Leases was $5850.0 for Q1 2026 at Azitra, down from $255776.0 in the prior quarter.
  • Across five years, Current Leases topped out at $298047.0 in Q2 2023 and bottomed at $5850.0 in Q1 2026.
  • A 5-year average of $92823.6 and a median of $15687.0 in 2024 frame the typical range for Current Leases.
  • Annual changes were most pronounced in 2025 — Current Leases surged 1492.03% — and 2026, when it slumped 97.54%.
  • Azitra's Current Leases stood at $287384.0 in 2022, then sank by 94.92% to $14600.0 in 2023, then advanced by 10.04% to $16066.0 in 2024, then jumped by 1492.03% to $255776.0 in 2025, then plunged by 97.71% to $5850.0 in 2026.
  • Business Quant data shows AZTR's Current Leases at $5850.0 in Q1 2026, $255776.0 in Q4 2025, and $14271.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Nanobiotix 1,769.80 Bn 1,769.74 Bn - -
2 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - -
3 BeOne Medicines 473.64 Bn 468.85 Bn 1.35 Bn 20.58 Mn
4 Vertex Pharmaceuticals 123.74 Bn 116.49 Bn 2.59 Bn -
5 Regeneron Pharmaceuticals 71.73 Bn 62.97 Bn 3.31 Bn 720.00 Mn
6 Belite Bio 62.10 Bn 62.10 Bn - -
7 Argenx Se 54.68 Bn 49.49 Bn 1.41 Bn 11.00 Mn
8 Alnylam Pharmaceuticals 38.13 Bn 35.12 Bn 959.66 Mn 45.66 Mn
9 Revolution Medicines 36.21 Bn 36.21 Bn - 16.61 Mn
10 Azitra 2.03 Mn 2.03 Mn - 5,850.00

Historic Data

Download Data
DateValue
Mar 31, 2026 5,850.00
Dec 31, 2025 255,776.00
Sep 30, 2025 14,271.00
Jun 30, 2025 16,854.00
Mar 31, 2025 237,647.00
Dec 31, 2024 16,066.00
Sep 30, 2024 15,687.00
Jun 30, 2024 15,317.00
Mar 31, 2024 14,954.00
Dec 31, 2023 14,600.00
Sep 30, 2023 14,254.00
Jun 30, 2023 298,047.00
Dec 31, 2022 287,384.00